Tag: TPNL

Blue Horseshoe Stocks: Options 5-Pack

GlaxoSmithKline plc GSK – Final Recap

Wednesday morning, we formulated an idea for the GSK options chain, which we updated our reader on just yesterday. But after a second consecutive solid session, we did observe some new highs in all three of our designated contracts, which were the GSK Weekly $39.50-40.50 Calls.

The updated two-day swing ranges on each of those ideas:

$39.50 Calls – Range: .65-1.40 – Max Gain: 115%
$40 Calls – Range: .15-1.00 – Max Gain: 566%
$40.50 Calls – Range: .10-.60 – Max Gain: 500%

GSK just continues the trend of fantastic options calls we’ve made in 2019 so far. While we don’t have exact figures worked out, it would seem at least 80-90% of the options ideas we’ve formulated have produced multi-bag gain opportunities, and we invite our readers to go through our newsletter feed at BlueHorseshoeStocks.com and see for yourself!
_____

Fresh Idea:
In the spirit of the great success we’ve had with options, we’re going to finish out the week in a big way with five fresh ideas!

Expedia Group, Inc. EXPE Weekly $134-136 Calls
Coty, Inv. COTY Weekly $8-9 Calls
SPDR S&P 500 ETF (SPY) Weekly $270.50-269 Puts
Sketchers USA Inc. SKX Weekly $30-33 Calls
Tupperware, Inc. TUP 07/19 $25 & $30 Calls

*Please note that our ideas for trading contracts with a weekly expiration on Fridays are intended STRICTLY for advanced level traders with disposable funds with which to work!

3pea International, Inc. TPNL

We also want to briefly recap the solid singkle-session performance of TPNL following its inclusion in yesterday’s morning’s premarket report. The stock produced an intraday run from 5.06 to 7.18, which works out to a gain of 42% and was good for the top gainer spot on the entire NASDAQ yesterday.

Extended Watchlist:
CNHC, DRVD, CPRX, DPW, MHK, PLX, BECN, CLD, DSKE

Blue Horseshoe Stocks: GSK Recap & More

GlaxoSmithKline plc GSK – Update

We attempted to keep our excellent 2019 options performance intact yesterday, and we did see some chances for intraday gains in the fresh idea for GSK we included in our premarket report.

The stock didn’t skyrocket by any means, rising by less than a dollar, but the activity was sufficient to produce the following moves in our designated contracts.

$39.50 Calls – Range: .65-1.24 – Max Gain: 91%
$40 Calls – Range: .15-.75 – Max Gain: 400%
$40.50 Calls – Range: .10-.40 – Max Gain: 300%
_____

Fresh Idea:
GRUB Weekly $86-87.50 Calls

Calix, Inc. CALX &
Vanda Pharmaceuticals, Inc. VNDA

We want to group these two stocks together this morning and tag them as bottom-watch plays. We’ll observe for the establishment of higher lows after their recent selloffs.

Both are now in the position of being extremely oversold, and exhibiting many of the conditions we routinely look for in potential recovery plays. We’ll observe their activity as we head into the end of the week.

Extended Watchlist:
DRVD, PYDS, NVCN, TPNL, BIOC